BioSpace News Archive

Biotech Beach

FDA Advisory Committee Votes in Support of Favorable Benefit-Risk Profile for neffy® (Intranasal (IN) Epinephrine) for the Treatment of Allergic Reactions (Type 1), Including Anaphylaxis

ARS Pharmaceuticals, Inc. (Nasdaq: SPRY) today announced that the U.S. Food and Drug Administration’s (FDA) Pulmonary-Allergy Drug Advisory Committee (PADAC) voted 16:6 in favor for adults, and 17:5 in favor for children (<18 years of age and ≥30 kg).

May 11, 2023
·
8 min read
Business

Willow Biosciences Reports First Quarter 2023 Results

Willow Biosciences Inc. has released its financial and operating results for the three months ended March 31, 2023, reporting significant progress to its operational platform and strong liquidity.

May 11, 2023
·
8 min read
Business

Nona Biosciences Announces Strategic Collaboration Agreement with PharmaEssentia Innovation Research Center

Nona Biosciences announced today it has entered into a strategic collaboration agreement with Massachusetts-based PharmaEssentia Innovation Research Center (PIRC) on Nona’s proprietary Harbour Mice® fully human antibody transgenic mice platform.

May 11, 2023
·
2 min read